Related Experiment Video
Updated: Aug 3, 2026

09:32
Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
Published on: September 10, 2017
Correlation between mutations in p53 gene and protein expression in human lymphomas
B Martinez-Delgado1, M Robledo, E Arranz
1Department of Genetics, Jimenez Diaz Foundation, Madrid, Spain.
American Journal of Hematology
|May 1, 1997
Summary
p53 gene mutations are infrequent in lymphomas, primarily occurring in high-grade B-cell non-Hodgkin
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- p53 protein overexpression and gene mutations show discordance in various tumors, including human lymphomas.
- Understanding this discrepancy is crucial for lymphoma diagnosis and treatment.
Purpose of the Study:
- To investigate the frequency and distribution of p53 gene mutations in a large series of lymphomas.
- To explore the relationship between p53 gene mutations and p53 protein overexpression in different lymphoma subtypes.
Main Methods:
- Analyzing exons 5-9 of the p53 gene in 94 lymphoma samples using Single-Strand Conformation Polymorphism (SSCP).
- Immunohistochemical staining with anti-p53 antibody DO-7 on 87 lymphoma samples.
- Sequencing the entire coding region for cases with discrepancies.
Main Results:
- p53 gene mutations were found in 7 out of 94 (7.4%) lymphomas, predominantly in high-grade B-cell non-Hodgkin's lymphomas (33%).
- p53 protein overexpression was observed in 16 out of 87 (18.4%) cases.
- Significant discrepancies were noted: 2 cases with mutations showed no overexpression, and 16 cases with overexpression had no detectable mutations in the studied exons.
Conclusions:
- p53 gene mutations are most common in high-grade B-cell NHLs and rare in Hodgkin's disease and low-grade lymphomas.
- The observed discrepancies suggest alternative mechanisms for p53 protein stabilization and indicate that immunohistochemistry alone cannot reliably predict p53 gene mutations in lymphomas.

